Tempest Therapeutics Stock Market Value
| TPST Stock | USD 0.92 0.01 1.10% |
| Symbol | Tempest |
Tempest Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tempest Therapeutics. If investors know Tempest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tempest Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Return On Assets (0.54) | Return On Equity (2.89) |
The market value of Tempest Therapeutics is measured differently than its book value, which is the value of Tempest that is recorded on the company's balance sheet. Investors also form their own opinion of Tempest Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tempest Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tempest Therapeutics' market value can be influenced by many factors that don't directly affect Tempest Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tempest Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tempest Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tempest Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tempest Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tempest Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tempest Therapeutics.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Tempest Therapeutics on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Tempest Therapeutics or generate 0.0% return on investment in Tempest Therapeutics over 30 days. Tempest Therapeutics is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat... More
Tempest Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tempest Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tempest Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 29.55 | |||
| Value At Risk | (8.53) | |||
| Potential Upside | 6.38 |
Tempest Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tempest Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tempest Therapeutics' standard deviation. In reality, there are many statistical measures that can use Tempest Therapeutics historical prices to predict the future Tempest Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tempest Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Tempest Therapeutics Backtested Returns
Tempest Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0882, which indicates the firm had a -0.0882% return per unit of risk over the last 3 months. Tempest Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tempest Therapeutics' Coefficient Of Variation of (978.51), risk adjusted performance of (0.07), and Variance of 26.13 to confirm the risk estimate we provide. The entity has a beta of 1.23, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tempest Therapeutics will likely underperform. At this point, Tempest Therapeutics has a negative expected return of -0.46%. Please make sure to validate Tempest Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Tempest Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Tempest Therapeutics has average predictability. Overlapping area represents the amount of predictability between Tempest Therapeutics time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tempest Therapeutics price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Tempest Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Tempest Therapeutics lagged returns against current returns
Autocorrelation, which is Tempest Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tempest Therapeutics' stock expected returns. We can calculate the autocorrelation of Tempest Therapeutics returns to help us make a trade decision. For example, suppose you find that Tempest Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tempest Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tempest Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tempest Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tempest Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Tempest Therapeutics Lagged Returns
When evaluating Tempest Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tempest Therapeutics stock have on its future price. Tempest Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tempest Therapeutics autocorrelation shows the relationship between Tempest Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Tempest Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.